Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The increase in slow wave sleep which followed administration of the 5-HT2 receptor antagonist, ritanserin, was not significantly different between a group of 12 recovered, drug free depressed patients and a group of 12 health matched controls. The results suggests that there is no underlying abnormality in the 5-HT2 receptor regulation of slow wave sleep in recovered depressives, and that abnormalities in this measure reported previously in such patients may have been caused by use of concomitant tricyclic antidepressant medication. The baseline sleep parameters did not differ between recovered depressives and controls with the exception of stage 1 sleep, which was increased in the patient group.

Type

Journal article

Journal

J Affect Disord

Publication Date

03/1992

Volume

24

Pages

177 - 181

Keywords

Adult, Aged, Depressive Disorder, Double-Blind Method, Electroencephalography, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Reaction Time, Receptors, Serotonin, Ritanserin, Sleep Stages, Sleep, REM